Refining General Principles of Antiepileptic Drug Treatments for Epilepsy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Keun Tae | - |
dc.contributor.author | Kim, Dong Wook | - |
dc.contributor.author | Yang, Kwang Ik | - |
dc.contributor.author | Lee, Soon-Tae | - |
dc.contributor.author | Byun, Jung-Ick | - |
dc.contributor.author | Seo, Jong-Geun | - |
dc.contributor.author | No, Young Joo | - |
dc.contributor.author | Kang, Kyung Wook | - |
dc.contributor.author | Kim, Daeyoung | - |
dc.contributor.author | Cho, Yong Won | - |
dc.date.accessioned | 2021-08-11T08:34:20Z | - |
dc.date.available | 2021-08-11T08:34:20Z | - |
dc.date.issued | 2020-07 | - |
dc.identifier.issn | 1738-6586 | - |
dc.identifier.issn | 2005-5013 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2673 | - |
dc.description.abstract | Antiepileptic drugs (AEDs) are the primary treatment strategy for epilepsy. As the use of AEDs has become more widespread and diverse over the past century, it has become necessary to refine the associated prescription strategies. This prompted the Drug Committee of the Korean Epilepsy Society to perform a systemic review of both international and domestic guidelines as well as literature related to medical treatment of epilepsy, and prepared a series of reviews to provide practical guidelines for clinicians to follow. This article is the first in a series on AED treatments for epilepsy in South Korea. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한신경과학회 | - |
dc.title | Refining General Principles of Antiepileptic Drug Treatments for Epilepsy | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3988/jcn.2020.16.3.383 | - |
dc.identifier.scopusid | 2-s2.0-85087807691 | - |
dc.identifier.wosid | 000550824700004 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Neurology, v.16, no.3, pp 383 - 389 | - |
dc.citation.title | Journal of Clinical Neurology | - |
dc.citation.volume | 16 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 383 | - |
dc.citation.endPage | 389 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002602786 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.subject.keywordPlus | WELL-CONTROLLED EPILEPSY | - |
dc.subject.keywordPlus | SEIZURE-FREE PATIENTS | - |
dc.subject.keywordPlus | STATUS EPILEPTICUS | - |
dc.subject.keywordPlus | ILAE COMMISSION | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | DEFINITION | - |
dc.subject.keywordPlus | RECURRENCE | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.subject.keywordPlus | IMMEDIATE | - |
dc.subject.keywordAuthor | epilepsy | - |
dc.subject.keywordAuthor | antiepileptic drugs | - |
dc.subject.keywordAuthor | anticonvulsants | - |
dc.subject.keywordAuthor | therapeutics | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.